He, Y., Yan, Y., Zhang, H., Lin, Y., Chen, Y., Yan, Y., . . . Du, G. (2016). Methyl salicylate 2-O-β-d-lactoside alleviates the pathological progression of pristane-induced systemic lupus erythematosus-like disease in mice via suppression of inflammatory response and signal transduction. Drug Des Devel Ther.
Citação norma ChicagoHe, Yang-Yang, et al. "Methyl Salicylate 2-O-β-d-lactoside Alleviates the Pathological Progression of Pristane-induced Systemic Lupus Erythematosus-like Disease in Mice Via Suppression of Inflammatory Response and Signal Transduction." Drug Des Devel Ther 2016.
Citação norma MLAHe, Yang-Yang, et al. "Methyl Salicylate 2-O-β-d-lactoside Alleviates the Pathological Progression of Pristane-induced Systemic Lupus Erythematosus-like Disease in Mice Via Suppression of Inflammatory Response and Signal Transduction." Drug Des Devel Ther 2016.